Search This Blog

Wednesday, November 6, 2019

Orchard Therapeutics EPS beats by $0.05, beats on revenue

Orchard Therapeutics (NASDAQ:ORTX): Q3 GAAP EPS of -$0.38 beats by $0.05.
Revenue of $1.92M (+38.1% Y/Y) beats by $1.51M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)